Pioglitazone delayed atheroma progression in patients with diabetes
Links shared publicly online about this topic.
- 598total visits
Pioglitazone delayed atheroma progression in patients with diabetes
Patients with type 2 diabetes who were treated with pioglitazone experienced improvements in triglyceride/HDL ratio that were associated with de
View full resource at endocrinetoday.com
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Type 2 Diabetes, Actos
Most Recently Shared on January 7, 2011 at 4:14 pm By:
#Pioglitazone delayed #atheroma progression in patients with #diabetes http://bit.ly/dH21XZ
Advertisement
